Complement Activation, Immunogenicity, and Immune Suppression as Potential Side Eff ects of Liposomes - Harnessing Biomaterials in Nanomedicine: Preparation, Toxicity, and Applications - page 326

References
1. Alberts, D. S., Liu, P. Y., Wilczynski, S. P., Clouser, M. C., Lopez, M. A.,
Michelin, D. P., Lanzotti, V. J., and Markman, M. (2008). Randomized
trial of pegylated liposomal doxorubicin (PLD) plus carboplatin
versus carboplatin in platinum-sensitive (PS) patients with recurrent
ovarian or peritoneal carcinoma after failure of initial platinum-based
chemotherapy (South West Oncology group protocol SO200). Gynecol.
Oncol . 108, pp. 90-94.
2. Altina, J. G., and Parish, C. R. (2006). Liposomal vaccines — targeting
the delivery of antigen. Methods 40, pp. 39-52.
3. Alving, C. R. (1991). Liposomes as carriers of antigens and adjuvants. J.
Immunol. Methods 140, pp. 1-13.
4. Alving, C. R., Kinsky, S. C., Haxby, J. A., and Kinsky, C. B. (1969). Antibody
binding and complement fixation by a liposomal model membrane.
Biochemistry 8, pp. 1582-1587.
5. Alving, C. R., Koulchin, V., Glenn, G. M., and Rao, M. (1995). Liposomes
as carriers of peptide antigens: induction of antibodies and cytotoxic T
lymphocytes to conjugated and unconjugated peptides. Immunol. Rev .
145, pp. 5-31.
6. Alving, C. R., and Swartz, G. M. (1991). Antibodies to cholesterol,
cholesterol conjugates, and liposomes: implications for atherosclerosis
and autoimmunity. Crit. Rev. Immunol. 10, pp. 441-453.
7. Alving, C. R., Swartz, G. M. J., Wassef, N. M., Ribas, J. L., Herderick, E.
E., Virmani, R., Kolodgie, F. D., Matyas, G. R., and Cornhill, J. F. (1996).
Immunization with cholesterol-rich liposomes induces anti-cholesterol
antibodies and reduces diet-induced hypercholesterolemia and plaque
formation. J. Lab. Clin. Med. 127, pp. 40-49.
8. Alving, C. R., Urban, K. A., and Richards, R. L. (1980). Influence of
temperature on complement-dependent immune damage to liposomes.
Biochim. Biophys. Acta 600, pp. 117-125.
9. Bangham, A. D. (1993). Liposomes: the Babraham connection. Chem.
Phys. Lipids 64, pp. 275-285.
10. Bangham, A. D., and Horne, R. W. (1964). Negative staining of
phospholipids and their structural modification by surface active
agents as observed in the electron microscope. J. Mol. Biol. 8, pp. 660-
668.
11. Barenholz, Y. (2006). Amphipathic weak base loading into preformed
liposomes having a transmembrane ammonium ion gradient: from the
bench to approved DOXIL, In Liposome Technology Vol 2 (G. Gregoriadis,
ed.), pp. 1-26. Informa Healthcare, New York, NY.